IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Regulus Therapeutics

Q1 2023 vs Q2 2023

Comparing institutional holders between quarters

Quarters

Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Endurance Wealth Management, Inc.
UNCHANGED
Shares675 from 675
Change0 (0%)
Value$0 ($0)
Filed 2023-08-09
Status
Endurance Wealth Management, Inc.
UNCHANGED67567500%$0$0$02023-08-09
Showing 1 of 1 institutions